Спутника v

Ministry of Health included the omicron strain in the recommendations for the treatment of COVID-19 , China became the leader in the production and export of vaccines, the WHO predicted the imminent registration of Sputnik V. The most relevant about the COVID pandemic is in the RBC review December 3......

Russian Foreign Minister Sergei Lavrov discussed the registration of the Russian vaccine Sputnik V with the head of the World Health Organization (WHO) Tedros Ghebreyesus, the Foreign Ministry reported on its website. The parties discussed over the phone topical issues of international cooperation, including for overcoming the COVID-19 pandemic . Lavrov and Ghebreyesus raised the issue of how to e...

The pandemic will end when 70% of the world's population has been vaccinated and medicines have been developed to treat those who get sick, said the head of the WHO European Office. According to him, The approval process for the Russian Sputnik V vaccine by the World Health Organization (WHO) will soon be completed, Hans Kluge, head of the organization's Regional Office for Europe, said. In an int...

Center them. M.P. Chumakova sent an application to the Ministry of Health for conducting clinical trials of the three-time administration of the CoviVac coronavirus vaccine, director of the institution Aidar Ishmukhametov said on the Rossiya 24 TV channel. “The Chumakov Institute applied to the clinic (clinical studies. -) for three injections. Three times administration after 21 days,” he said. A...

The European Medicines Agency (EMA) has recommended approval for the use of the Nuvaxovid vaccine from the American company Novavax, according to the regulator's website. “After a thorough assessment, the EMA Committee for Medicinal Products for Human Use (CHMP) reached general agreement that the vaccine data were reliable and met EU criteria for efficacy, safety and quality,” the report said. Thi...

Scientists of the Russian Academy of Sciences evaluated the version of the development of "omicron" by a biohacker, experts called an "unusual" symptom when infected with "omicron", new coronavirus restrictions in Europe. The most relevant about the COVID pandemic is in the RBC review December 20, 11:45 Moscow time Coronavirus Russia Moscow World +27......

The World Health Organization (WHO) may recognize the Russian COVID-19 vaccine Sputnik V in the coming months, Presidential Press Secretary Dmitry Peskov said on the Rossiya 1 TV channel. “I am deeply convinced that literally within a few months, foreseeable prospects, the WHO will nevertheless recognize Sputnik and will also be able to move forward along this path with the Europeans,” Peskov said...

The World Health Organization (WHO) is evaluating the technical dossier of Sputnik V and is waiting for more information on the vaccine. WHO spokeswoman Margaret Harris spoke about this in an interview with RT. “We are still evaluating the technical dossier for the Sputnik V vaccine and waiting for more information. The process is ongoing,” she said. At the same time, Harris noted that WHO certifi...

The one-component Russian vaccine "Sputnik Light" is registered in the state of Saint Vincent and the Grenadines, located in the Caribbean Sea. A message about this appeared on the Sputnik V Twitter account. Sputnik Light, an effective standalone COVID-19 vaccine and powerful booster, has been approved in St. Vincent and the Grenadines,” the developers of the drug said. In October, the Russian Dir...

The infection rate in Russia has dropped below 30 thousand, checking the effectiveness of Sputnik V on Omicron. The most relevant about the COVID pandemic is in the RBC review December 12, 11:30 Moscow time Coronavirus Russia Moscow World +29929 (per day) 10 million Infected 0 +1132 (per day) 289.5 thousand Died +2862 (per day) 1, 9 million Infected ......

Experts will test the effectiveness of the Russian coronavirus vaccine Sputnik V against the omicron strain within ten days, Alexander Gintsburg, director of the Gamaleya Center, told RIA Novosti. “I think 10 days is enough to test the effectiveness,” Gunzburg said. Earlier, he said that the center assembled the design of the Omicron vaccine, but scientists see no reason to change the drug. Gunzbu...

The introduction of booster doses of mRNA drugs, which include Pfizer and Moderna, three months after the main course may have unintended consequences, according to the Center. Gamaleya. This is stated on Twitter "Sputnik V". “The hasty global roll-out of tri-monthly booster vaccinations with mRNA preparations without long-term testing may have unforeseen safety [health] implications and highlight...

Vaccination of adolescents aged 12 to 17 against coronavirus infection will begin in Russia before the end of this year. This was announced by the Minister of Health Mikhail Murashko, reports TASS. “By the end of the year, we will carry out the first vaccination [among teenagers] throughout Russia,” the minister said. Murashko called the date for the introduction of the vaccine against COVID-19 fo...

In October Russiashipped abroad a record volume of "other human vaccines" - almost the same as during the whole summer. Since the beginning of the year, the export of the main "vaccine code", which has grown sharply since the start of shipments of "Sputnik V", has exceeded $1.2 billion. Over the ten months of this year, Russian exports of “other vaccines for humans” (according to the classificatio...

In Russia, the validity period of PCR tests has been reduced, the fate of the laws on QR codes has not yet been decided, the Center. Gamaleya will start testing a new vaccine, Poland is strengthening quarantine measures. The most relevant about the COVID pandemic is in the RBC review December 9, 11:45 Moscow time Coronavirus Russia Moscow World +3......

Center named after N.F. Gamalei, who developed Sputnik V, will conduct the first two phases of clinical trials of a new coronavirus vaccine on volunteers, follows from a contract on the public procurement portal, Pharmaceutical Bulletin writes. The new drug, unlike Sputnik V, was developed on the basis of virus-like particles (VLP). They do not contain the genetic material of the pathogen, but mim...

An inspection by World Health Organization (WHO) experts to Russia to evaluate the Sputnik V vaccine against COVID-19 will take place no earlier than January 2022. About this, as reported by "RIA Novosti", said the press service of the organization. In November, the WHO met with representatives of the Russian Direct Investment Fund. “The company has committed to provide a detailed roadmap for data...

An inspection by World Health Organization (WHO) experts to Russia to evaluate the Sputnik V vaccine against COVID-19 will take place no earlier than January 2022. About this, as reported by "RIA Novosti", said the press service of the organization. In November, the WHO met with representatives of the Russian Direct Investment Fund. “The company has committed to provide a detailed roadmap for data...

Due to the lower concentration of active particles, the children's Sputnik M is almost a third cheaper than the adult Sputnik V. The first batches of the drug are already ready, it will be introduced into civilian circulation in a few weeks, The maximum selling price for the Sputnik M coronavirus vaccine for teenagers was 6......

About 150 thousand doses of the Sputnik M vaccine against coronavirus for adolescents aged 12 to 17 years have been produced in Russia. This was stated by the director of the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei Alexander Gintsburg, RIA Novosti reports. “We have already released about 15......

Alexander Gunzburg The nasal vaccine, developed by the Gamaleya Research Center for Epidemiology and Microbiology, will also protect those who have not previously been vaccinated with Sputnik V. About this "RIA Novosti" said the director of the center Alexander Gintsburg. “For sure it will be if a person has been vaccinated with working vaccines that give antibodies,” Gunzburg said, answering a re...

The Gamaleya Center began to adapt vaccines to the new strain of coronavirus omicron according to the protocol. In spite of this, Experimental work on adapting the Sputnik V vaccine against coronavirus for the omicron strain will take no more than 10 days. This was announced by the head of the Center. Gamalei Alexander Gintsburg, Interfax reports. According to him, it will take up to 5......

Veronika Skvortsova The Federal Medical and Biological Agency (FMBA) is ready to make a test system to detect a new strain of coronavirus in nine days. This was stated by the head of the FMBA Veronika Skvortsova on the air of the Russia 24 TV channel. “Now we will very quickly make a kit for this omicron, because the design takes three to four days, five days to create this test system itself,” sa...

The St. Petersburg Transport Committee has published a list of countries where residents of the Northern capital can fly from Pulkovo during the winter holidays. The list, which appeared on the agency's website on November 29, includes 16 destinations. In addition to Uzbekistan, Belarus, Kyrgyzstan, Armenia, Tajikistan, Kazakhstan, Azerbaijan and Moldova, St. Petersburg residents still have the op...

Additionally vaccinated with the nasal vaccine against COVID-19 will not spread the virus. This was announced by the director of the Research Center of Epidemiology and Microbiology. Gamalei Alexander Gintsburg, RIA Novosti reports. According to him, when vaccinated with a nasal vaccine, so-called secretory antibodies are formed on the mucous membrane, which contain a large number of antibodies. “...

Scientists of the Center Gamalei will test the effectiveness of the drug against the new SARS-CoV-2 variant and, if necessary, replace the strain in the vaccine. Specialists of the Center Gamaleya, if necessary, can adapt the Sputnik V vaccine to a new strain of coronavirus B.1.1.529, which was found in southern Africa. This was stated to RBC by the head of the center Alexander Gintsburg. “When we...

No side effects have been found after using the nasal coronavirus vaccine. This was stated by the director of the National Research Center for Epidemiology and Microbiology. N.F. Gamalei Alexander Gintsburg, reports TASS. “So far, we do not see side effects from the nasal vaccine. Efficiency will need to be checked,” Gunzburg said. In response to the question whether such a vaccine could be danger...

The effectiveness of the Russian Sputnik V vaccine against COVID-19 was 80% in the period of six to eight months after the introduction of the second component, according to the San Marino Ministry of Health, the Russian Direct Investment Fund (RDIF), which distributes the drug abroad, said. “The effectiveness of Sputnik V after six to eight months is much higher compared to officially published d...

Alexander Gunzburg There are different options for the study of the nasal vaccine against COVID-19 - both those who have already been vaccinated with Sputnik V and those who do not have antibodies will become participants, said the director of the National Research Center for Epidemiology and Microbiology. Gamalei Alexander Gintsburg. His words are reported by RIA Novosti. “There are different opt...

Recommendations for the use of a new nasal vaccine against COVID-19 should be given only after the publication of official results of the study and its registration. This was reported to RBC by Sergei Voznesensky, Associate Professor of the Department of Infectious Diseases. Previously head of the Center Gamalei Alexander Gintsburg said that people vaccinated with the injection vaccine, who will a...